May 7 (Reuters) - Myriad Genetics Inc ( MYGN ):

* MYRIAD GENETICS ANNOUNCES REORGANIZATION OF EUROPEAN

OPERATIONS

AND SALE OF ENDOPREDICT BUSINESS

* MYRIAD GENETICS INC ( MYGN ): TO SELL ITS ENDOPREDICT BUSINESS TO

EUROBIO

SCIENTIFIC

* MYRIAD GENETICS INC ( MYGN ): WILL LICENSE EUROBIO RIGHT TO SELL

PROLARIS

IN VITRO DIAGNOSTIC KITS OUTSIDE U.S.

Source text for Eikon:

Further company coverage: